Navigation Links
Johnson & Johnson Reports 2014 Second-Quarter Results:
Date:7/15/2014

rational sales growth were STELARA® (ustekinumab), a biologic approved for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis; REMICADE® (infliximab) and SIMPONI®/SIMPONI® ARIA™ (golimumab), biologics approved for the treatment of a number of immune-mediated inflammatory diseases;  INVEGA®  SUSTENNA®/XEPLION® (paliperidone palmitate), a once-monthly, long-acting, injectable atypical antipsychotic for the treatment of schizophrenia in adults; and PREZISTA® (darunavir), a treatment for HIV.

Sales results were negatively impacted by loss of exclusivity for ACIPHEX® (rabeprazole), a proton pump inhibitor for gastrointestinal disorders, and CONCERTA® (methylphenidate HCI) for the treatment of attention deficit hyperactivity disorder.

During the quarter, the U.S. Food and Drug Administration (FDA) and the European Commission (EC) granted approval of SYLVANT® (siltuximab) for the treatment of patients with multicentric Castleman's disease who are human immunodeficiency virus negative and human herpesvirus-8 negative. In addition, the EC granted approval for VOKANAMET®, a fixed-dose therapy combining canagliflozin and immediate release metformin hydrochloride in a single tablet for the treatment of adults with type 2 diabetes; OLYSIO® (simeprevir) for the treatment of adult patients with genotype 1 or 4 chronic hepatitis C; and for INVEGA® (paliperidone ER) to extend its adult indication of schizophrenia to include adolescents aged 15 years and older.

In addition, a supplemental New Drug Application (sNDA) was submitted to the FDA seeking approval for simeprevir in combination with the nucleotide analog NS5B polymerase inhibitor sofosbuvir developed by Gilead Sciences, Inc.  Additional
'/>"/>

SOURCE Johnson & Johnson
Copyright©2014 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27 28 29 30 31 32 33

Related medicine technology :

1. Adaptive Announces a Biomarker Discovery Agreement with Johnson & Johnson Innovation
2. Janssen Pharmaceutical Companies of Johnson & Johnson Submit Citizen Petition to the U.S. FDA Regarding Naming of Biosimilars
3. Healthcare Companies Report Stock Price Updates, and Medical System Integration - Research Report on Johnson & Johnson, Geron, Ligand Pharmaceuticals, Masimo, and Capital Senior Living
4. Janssen, the Pharmaceutical Companies of Johnson & Johnson, Announces First-of-its-Kind Drug Donation Program for HIV Treatment-Experienced Children
5. Johnson & Johnson Settlement Resolves Metal Hip Lawsuits But Weak Oversight Of Medical Device Industry Leaves Hundreds of Thousands of Patients Vulnerable
6. KV Pharmaceutical Company Completes New Board with Appointment of Former Johnson & Johnson Executive
7. Legal Actions, Quarterly Dividends, Collaborations, and New Appointments - Research Report on Johnson & Johnson, Zoetis, Abbott, Teva Pharmaceuticals, and Baxter
8. Johnson & Johnson Completes Acquisition Of Aragon Pharmaceuticals, Inc.
9. Johnson & Johnson Reports 2013 Second-Quarter Results:
10. Johnson & Johnson Announces Definitive Agreement To Acquire Aragon Pharmaceuticals, Inc.
11. Janssen and Johnson & Johnson to Provide Webcast Presentation of Simeprevir Phase 3 Clinical Data Presented at The International Liver Congress of the European Association for the Study of the Liver (EASL)
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/20/2014)... The National Association of Drug Diversion ... by the real-time, pseudoephedrine (PSE) blocking system in ... Exchange (NPLEx), automatically blocks unlawful pseudoephedrine sales and ... and make arrests. Data released by NPLEx shows ... blocked the sale of more than 7,481 boxes of ...
(Date:8/20/2014)... LUTHERVILLE, Md. , Aug. 20, 2014 /PRNewswire/ ... today lauded the latest results achieved by the ... known as the National Precursor Log Exchange (NPLEx), ... enforcement officials track down methamphetamine offenders and make ... in Michigan blocked the ...
(Date:8/20/2014)... , Aug. 20, 2014 ... research report is available in its ... Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing ... http://www.reportlinker.com/p01618925/The-Market-for-Hospital-Acquired-Infection-Control-Sterilization-Disinfection-Testing-and-Treatment.html Given the ... (HAIs), demand has increased for solutions ...
Breaking Medicine Technology:Kansas's Stop-Sale System Achieves Significant Results In Battle Against Meth 2Michigan's Stop-Sale System Achieves Significant Results In Battle Against Meth 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 2The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 3The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 4The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 5The Market for Hospital-Acquired Infection Control (Sterilization, Disinfection, Testing and Treatment) 6
(Date:8/21/2014)... Living in a quality residential community means ... with it. A quality Home Owners Association like the ... available. , Simpson Mill Plantation, ... Association Management, LLC made a recent investment in a ... an additional amenity for their neighborhood. , Situated near ...
(Date:8/21/2014)... 21, 2014 Recently, Van Uden ... patients. Alternative medicine is on the rise and ... According to The Fiscal Times, young people are ... conventional medicine. , The Fiscal Times published an ... are embracing alternative medicine. The article can be ...
(Date:8/21/2014)... the coronary arteries of chronic kidney disease patients may ... to a new study in the Journal of ... Researchers at the Johns Hopkins Bloomberg School of Public ... used measures of subclinical atherosclerosis in predicting the risk ... Approximately 50 percent of all patients with chronic kidney ...
(Date:8/21/2014)... cancer appear to have better survival if they ... Author: Uchechukwu C. Megwalu, M.D., M.P.H., of the ... York, and colleagues. , Background: Approximately 11,000 to ... year and squamous cell carcinoma accounts for the ... total surgical removal of the larynx with postoperative ...
(Date:8/21/2014)... Improv performers from Fun House Theatre and Film ... Turtle Creek memory care community in Dallas. The Unicorn ... ages 10 to 16, delivers a groundbreaking and fun-filled ... troupe's philosophy is that improv is based on relationships, ... audiences regardless of their circumstance — including bringing joy ...
Breaking Medicine News(10 mins):Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 2Health News:Recreation is the Heart of the Community at Simpson Mill Plantation; Chooses American Parks Company™ for New Playground Equipment 3Health News:Van Uden Center Sees Growth in Alternative Medicine 2Health News:Measuring calcium buildup to predict heart disease in those with chronic kidney disease 2Health News:Surgery associated with better survival for patients with advanced laryngeal cancer 2Health News:Unicorn Clearance Improv Troupe Brings Laughter to Residents with Dementia at Silverado Memory Care 2
... Citizens by Enhancing Their ... Own Plans, ... help them prepare for one of the most daunting public,health emergencies: an ... Policy (CIDRAP) at,the University of Minnesota and the Pew Center on the ...
... Organization Urges Consumers to ... Beware!, ... Society of Cosmetic Dermatology and Aesthetic,Surgery (ASCDAS), responded to the recent decision ... of Healing Arts to ban the,liposuction treatment, Lipodissolve. "This procedure is still ...
... or circulating tumour cells (CTCs), are known to be associated ... Now, for the first time, a group of scientists have ... chemotherapy treatment and hence may be able to identify those ... such treatment in future. , Dr. Julia Jckstock, from the ...
... Driven by Launches, of Disease-Modifying Therapies, According to a New ... ... Resources, WALTHAM, Mass., Sept. 24 Decision Resources, one of ... that by 2016 Genentech/Roche,s Lucentis and Eli,Lilly,s ruboxistaurin will drive the ...
... DUBLIN, Ohio, Sept. 24 Cardinal Health, a,global provider ... of health care, today announced President and Chief Executive,Officer ... effective Nov. 8,following the company,s 2007 annual shareholder meeting. ... who plans to retire,at the end of the company,s ...
... University of Warwick, and University College London, have found that ... death from cardiovascular disease. However they have also found that ... double the risk of death. , In research to be ... Society, Professor Francesco Cappuccio from the University of Warwicks Warwick ...
Cached Medicine News:Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 2Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 3Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 4Health News:Peer-Reviewed, Online Database Showcases Local, County and State Pandemic Planning 5Health News:Lipodissolve - Is it Safe??? 2Health News:Cancer cells in blood can identify risk of recurrence in breast cancer 2Health News:Cancer cells in blood can identify risk of recurrence in breast cancer 3Health News:Genentech/Roche's Lucentis and Eli Lilly's Ruboxistaurin Will Drive the Diabetic Retinopathy and Nephropathy Drug Markets 2Health News:Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years 2Health News:Cardinal Health Names CEO R. Kerry Clark as Chairman; Company Founder Robert D. Walter to Retire After 36 Years 3Health News:Researchers say lack of sleep doubles risk of death... but so can too much sleep 2
BioSoft alcohol gel hand antiseptic with soothing moisturizers is a fast-acting, broad-spectrum antimicrobial solution. BioSoft alcohol gel hand antiseptic applies easily, requires no rinsing and dri...
... Scrub Care povidone-iodine (PVP-I) antimicrobial solutions ... control in all hospital and health-care settings. ... gel have a broad spectrum of activity, ... bacteria that may cause infection. The new ...
... hand sanitizers like Aplicare No Rinse Isopropyl ... as the recommended product for hand disinfection ... Guidelines for hand hygiene., According to the ... be prevented with better infection control programs. ...
This is long known for its purity and mildness, Castile Soap is also an effective cleaning agent that is used in a variety of applications. It rinses clean while leaving the skin soft and healthy....
Medicine Products: